Skip to main content
TipRanks
Go Ultimate75% OFF

Glenmark Life Sciences Limited (ALIVUS) Revenue

6 Followers

Glenmark Life Sciences Limited Revenue

Glenmark Life Sciences Limited had a revenue of 5.88B in the quarter ending Sep 30, 2024, with -0.11%. This bring the company's revenue in the last twelve months to 11.90B, Decreased 0.05%. In the fiscal year ending Mar 31, 2025, Glenmark Life Sciences Limited had annual revenue of 25.52B with 11.76% growth.

Revenue (ttm)
11.90B
Revenue Growth
8.19%
P/S Ratio
6.98
Revenue/Employee
INR 11,231,655
Employees
2,272
Market Cap
INR 178.01B

Revenue Chart

Glenmark Life Sciences Limited Revenue - Annual

05B10B15B20B25B30B2.48M15.37B18.85B21.61B22.83B25.52B201820202021202220242025
Revenue History
Download to Excel
IN:ALIVUS revenue history
Fiscal End DateRevenueChangeGrowth
Mar 31, 202525.52B2.69B11.76%
Mar 31, 202422.83B1.22B5.64%
Mar 31, 202221.61B2.76B14.64%
Mar 31, 202118.85B3.48B22.63%
Mar 31, 202015.37B15.37B619784.27%
Mar 31, 20182.48M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
IN:ALIVUS11.90B
IN:DIVISLAB121.91B
IN:GRANULES58.83B
IN:LAURUSLABS78.23B
IN:NEULANDLAB23.07B
IN:SOLARA15.35B